Stock Track | Concentrix Corp Soars 12.72% on Strong Q1 Results, Raised Guidance, and AI Success

Stock Track
2025/03/27

Concentrix Corp (CNXC) shares are soaring 12.72% in pre-market trading on Thursday, following the release of its impressive first-quarter 2025 financial results and raised full-year guidance. The customer experience solutions provider significantly outperformed analyst expectations, demonstrating robust growth in key financial metrics and success in artificial intelligence deployment.

The company reported adjusted earnings per share (EPS) of $2.79 for Q1, handily beating the analyst consensus estimate of $2.58. This represents an 8.56% increase from the $2.57 per share reported in the same period last year. Concentrix's revenue for the quarter came in at $2.37 billion, growing 1.3% year over year on a constant currency basis. Other notable achievements include adjusted EBITDA of $374 million and an improved adjusted operating margin of 13.6%.

Concentrix's strong performance can be attributed to its success in deploying GenAI solutions at scale and the growing traction of its iX Hello product suite. The company has positioned itself as a leader in AI deployment, with thousands of seats already deployed for the iX Hello platform. Chris Caldwell, President and CEO of Concentrix, expressed confidence in the company's trajectory, stating, "With a solid start to the year, we remain on track to deliver ongoing constant currency revenue growth, while expanding margins and growing free cash flow in 2025 and beyond." The raised full-year revenue guidance, now expected between $9.49 billion and $9.635 billion, further bolsters investor confidence in Concentrix's growth prospects. Additionally, BofA Global Research has raised its price objective for Concentrix from $58.00 to $59.00, reflecting the positive sentiment surrounding the company's performance and outlook.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10